Companies Dominating the Local Anesthesia Drugs Landscape
- Aspen Pharmacare
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Fresenius SE & Co. KGaA
- Glenmark Pharmaceutical Inc.
- Mylan N.V.
- Pacira Pharmaceuticals, Inc.
- Pfizer Inc.
- Septodont
- Teva Pharmaceutical Industries Ltd
- Novartis AG
- Baxter International Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of dengue testing is estimated at USD 710.8 million.
Dengue Testing Market size was valued at USD 675.22 million in 2024 and is likely to cross USD 1.47 billion by 2037, expanding at more than 6.2% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is likely to account for largest revenue share by 2037, owing to high prevalence of dengue virus infections in several countries of the region such as Malaysia, Philippines and Vietnam, and the increase in government expenditure on improving healthcare infrastructure along with growing emphasis on carrying out dengue awareness campaigns in the region.
The major players in the market include Pfizer Inc., Septodont, Teva Pharmaceutical Industries Ltd, Novartis AG, Baxter International Inc. among others.
